← Back to Dashboard

HBV

Hepadnaviridae · Orthohepadnavirus

Not considered to have pandemic potential
20
Approved Drugs
1
Phase 3
6
Phase 2
22
Preclinical
49
Total Compounds

Antiviral Compounds

TenofovirHBVNucleotide analog RT inhibitor
FDA approved
FDAChinaRussia
Viral RT
EntecavirHBV
FDA approved
FDAJapanChina
DNA polymerase
TelbivudineHBVViral DNA chain termination
FDA approved
FDA
DNA polymerase
AdefovirHBV
FDA approved
FDA
DNA polymerase
Tenofovir disoproxil fumarateHBV
FDA approved
FDAJapanChina
DNA polymerase
Tenofovir alafenamideHBV
FDA approved
FDAJapanChina
DNA polymerase
ClevudineHBV
Approved (other)
EMA
DNA polymerase
Besifovir dipivoxil maleateHBV
Approved (other)
South Korea
selgantolimodHBV
Phase 2
GLS4HBV
Phase 2
Tenofovir disoproxilHBV
FDA approved
FDAJapanChina
Adefovir dipivoxilHBVViral DNA chain termination
FDA approved
FDAJapan
Viral RNA pol
AmantadineHBVViroporin inhibitor; blocks viral ion channel activity
Approved (other)
Japan
Viral ion channel (viroporin)
AVN-944HBVIMPDH inhibitor
Preclinical
Human IMPDH
BexaroteneHBVUnknown
Preclinical
Human RAR
BortezomibHBVProteasome inhibitor (26S subunit)
Preclinical
Human proteasome
DexelvucitabineHBVNucleoside RT inhibitor
Preclinical
Viral RT
ElvucitabineHBVNucleoside analog RT Inhibitor
Preclinical
Viral RT
EmodinHBV
Preclinical
Human (multiple)
EmtricitabineHBVviral nucleoside reverse transcritase inhibitor
Approved (other)
JapanRussia
Viral RT
EzetimibeHBVIntestinal cholesterol and related phytosterol absorption inhibitor
Preclinical
Human cholesterol transporter
FamciclovirHBVViral DNA Polymerase Inhibitor
Approved (other)
JapanRussia
Viral DNA pol
FiacitabineHBVInhibits viral DNA synthesis
Preclinical
Viral RT
FoscarnetHBVPyrophosphate analog DNA polymerase inhibitor
Approved (other)
Japan
Viral RT
GanciclovirHBVViral RNA polymerase inhibitor
Approved (other)
JapanChina
Viral RT
Showing 1 to 25 of 49 results
Page 1 of 2